John Dylewski, MD
Clinical Cardiac Electrophysiology · Steubenville, OHNPI 1881652287
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Biotronik Inc. at 38.3% of the total. Reporting peaked in 2022 at $5,545 and has fallen 60.4% since, to $2,197 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OH, where the typical reported total is $17,892.
Across 164 payments — averaging $123.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$8K
- Sanofi-aventis U.S. LLC$5K
- Abbott$4K
- Boston Scientific$2K
- Medtronic$388
- Heartflow, Inc.$148
- plus $747 from 12 others
Across 2 payments — averaging $53,825 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Withings, Inc.$108K
What the payments were for
- Speaking & faculty fees$4,14721%
- Travel & lodging$7,96139%
- Food & beverage$8,11940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 31 | $7,752 |
| Sanofi-aventis U.S. LLC | 25 | $4,590 |
| Abbott | 73 | $4,310 |
| Boston Scientific | 9 | $2,291 |
| Medtronic(2 entities) | 4 | $388 |
| Heartflow, Inc. | 1 | $148 |
| Merck | 3 | $142 |
| GSK | 1 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $110 |
| Impulse Dynamics (USA) Inc. | 1 | $106 |
| Johnson & Johnson(2 entities) | 2 | $70 |
| Lundbeck LLC | 3 | $63 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Bardy Diagnostics, Inc. | 2 | $20 |
| Baxter Healthcare | 1 | $16 |
| Pfizer | 1 | $16 |
| Infobionic, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MULTAQ$4,147
- Solia$3,778
- BioMonitor$3,778
- Edora$2,549
- Rivacor$2,549
- Acticor$2,549
- GENERAL - THERAPIES$2,121
- Edora 8 DR-T$1,591
- Rivacor 7 DR-T$1,591
- Acticor 7 VR-T DX$1,591
- AMPLATZER AMULET$1,164
- ENSITE$766
- Sentus$362
- Plexa$362
- OPTIMIZER$212
- FFRct$148
- ARCTIC FRONT ADVANCE$124
- Quadra Assura CRT Defibrillator$124
- TRELEGY ELLIPTA$122
- COBALT DR MRI SURESCAN$121
How this compares
$20,226 in reported general payments places this provider in the 50th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MultaqDronedarone Hcl | 57 | $64,111 |
| EliquisApixaban | 52 | $42,145 |
| Propafenone Hcl ErPropafenone Hcl | 11 | $1,189 |
| Flecainide Acetate | 12 | $481 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $429 |
| SotalolSotalol Hcl | 27 | $324 |
| Nifedipine ErNifedipine | 19 | $285 |
| Carvedilol | 21 | $229 |
| Atenolol | 22 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $4,590 | $64,11157 claims |
| PfizerEliquis | $16 | $42,14552 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Steubenville
- Juergen KlooSteubenville$30K
- Anish AminColumbus$1.1M
- Walid SalibaCleveland$511K
- Mohamed KanjBeachwood$442K
- John HummelColumbus$275K
- Bruce WilkoffCleveland$213K
- Alexandru CosteaCincinnati$188K
- Auroa BadinColumbus$188K
- Gaurang GandhiCincinnati$179K
- Ralph AugostiniColumbus$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.